[Perfusion protection of ischemic liver using perfluorocarbon emulsion]

Area of Science:

• Biomedical Engineering
• Organ Preservation
• Ischemia Research

Background:

• Ischemic injury to the liver is a significant clinical challenge.
• Hypothermic perfusion is used to preserve organs during transplantation and surgery.
• Developing effective anti-ischemic agents is crucial for improving organ viability.

Purpose of the Study:

• To evaluate the efficacy of Fluorocarbon emulsion as an anti-ischemic agent for the liver.
• To determine the optimal concentration of Fluorocarbon emulsion for liver protection during hypothermic perfusion.
• To investigate the protective effects of Fluorocarbon emulsion against ischemia-reperfusion injury in an isolated liver model.

Main Methods:

• Experiments were conducted on 47 rabbits.
• Isolated livers were subjected to 90 minutes of ischemia.
• Hypothermic perfusion was employed, with varying concentrations of Fluorocarbon emulsion administered.
• Liver protection was assessed based on indicators of ischemic damage.

Main Results:

• Different concentrations of Fluorocarbon emulsion were tested for their anti-ischemic properties.
• The 12% concentration of Fluorocarbon emulsion demonstrated the most significant protective effect.
• This concentration was identified as the optimal level for perfusion of isolated livers.

Conclusions:

• Fluorocarbon emulsion shows promise as a protective agent against liver ischemia.
• A 12% concentration is recommended for Fluorocarbon emulsion perfusion in isolated liver preservation.
• Further research may explore clinical applications of this anti-ischemic strategy.